Table 3.
Anti-bacterial activity of the synthesized AgNPs.
Treatments | ZOI (mm) | ||||
---|---|---|---|---|---|
S. aureus | MRSA | S. epidermidis | K. pneumoniae | E. coli | |
MHB | 0 | 0 | 0 | 0 | 0 |
GAE | 0 | 0 | 0 | 0 | 0 |
C-AgNPs | 9.8 | 9.8 | 8.4 | 11 | 6.2 |
GAC-AgNPs | 0 | 0 | 0 | 0 | 0 |
GA-AgNPs_0.4g | 14.2 | 13.8 | 20 | 13.6 | 11.2 |
GA-AgNPs_0.5g | 13 | 9.8 | 19 | 14.6 | 10.2 |